These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16709820)

  • 21. TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.
    Geng D; Kaczanowska S; Tsai A; Younger K; Ochoa A; Rapoport AP; Ostrand-Rosenberg S; Davila E
    Cancer Res; 2015 May; 75(10):1959-1971. PubMed ID: 25795705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
    Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
    J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
    Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR
    J Immunol; 2003 Oct; 171(8):4054-61. PubMed ID: 14530326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
    Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
    Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
    Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
    J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin.
    Bachmann M; Horn K; Poleganov MA; Paulukat J; Nold M; Pfeilschifter J; Mühl H
    Cell Microbiol; 2006 Feb; 8(2):289-300. PubMed ID: 16441439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.
    Jarnicki AG; Conroy H; Brereton C; Donnelly G; Toomey D; Walsh K; Sweeney C; Leavy O; Fletcher J; Lavelle EC; Dunne P; Mills KH
    J Immunol; 2008 Mar; 180(6):3797-806. PubMed ID: 18322186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
    Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
    Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-step enhanced cancer immunotherapy with engineered
    Zheng JH; Nguyen VH; Jiang SN; Park SH; Tan W; Hong SH; Shin MG; Chung IJ; Hong Y; Bom HS; Choy HE; Lee SE; Rhee JH; Min JJ
    Sci Transl Med; 2017 Feb; 9(376):. PubMed ID: 28179508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences.
    Ikeda RK; Miller M; Nayar J; Walker L; Cho JY; McElwain K; McElwain S; Raz E; Broide DH
    J Immunol; 2003 Nov; 171(9):4860-7. PubMed ID: 14568966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
    J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.
    Lu H; Wagner WM; Gad E; Yang Y; Duan H; Amon LM; Van Denend N; Larson ER; Chang A; Tufvesson H; Disis ML
    J Immunol; 2010 May; 184(9):5360-7. PubMed ID: 20308630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
    Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
    J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Microenvironment-Regulating Immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity.
    Uthaman S; Pillarisetti S; Hwang HS; Mathew AP; Huh KM; Rhee JH; Park IK
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):4844-4852. PubMed ID: 33486952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1.
    Cunningham AF; Khan M; Ball J; Toellner KM; Serre K; Mohr E; MacLennan IC
    Eur J Immunol; 2004 Nov; 34(11):2986-95. PubMed ID: 15384042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response of human and mouse dendritic cells to VEGF determines interspecies discrepancies in tumor-mediated TH1/TH2 polarity shift.
    Block MS; Nevala WK; Leontovich AA; Markovic SN
    Clin Cancer Res; 2011 Apr; 17(7):1776-83. PubMed ID: 21349994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
    Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
    Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.
    Lee SE; Kim SY; Jeong BC; Kim YR; Bae SJ; Ahn OS; Lee JJ; Song HC; Kim JM; Choy HE; Chung SS; Kweon MN; Rhee JH
    Infect Immun; 2006 Jan; 74(1):694-702. PubMed ID: 16369026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.